Stevanato Group (NYSE:STVN - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 0.544-0.587 for the period, compared to the consensus estimate of 0.570. The company issued revenue guidance of $1.2 billion-$1.3 billion, compared to the consensus revenue estimate of $1.2 billion.
Stevanato Group Price Performance
Shares of Stevanato Group stock traded up €0.90 ($0.98) on Monday, hitting €22.46 ($24.41). 621,013 shares of the company traded hands, compared to its average volume of 352,047. Stevanato Group has a 52 week low of €16.56 ($18.00) and a 52 week high of €33.49 ($36.40). The business has a 50-day simple moving average of €21.38 and a 200 day simple moving average of €20.55. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. The stock has a market capitalization of $6.80 billion, a P/E ratio of 47.79, a price-to-earnings-growth ratio of 7.18 and a beta of 0.60.
Stevanato Group (NYSE:STVN - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of €0.20 ($0.22). Stevanato Group had a net margin of 10.47% and a return on equity of 9.86%. The company had revenue of €352.68 million for the quarter, compared to the consensus estimate of €346.26 million. Research analysts expect that Stevanato Group will post 0.5 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on STVN. Morgan Stanley restated an "equal weight" rating and set a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a report on Tuesday, December 3rd. UBS Group reduced their price target on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research report on Friday. William Blair reiterated an "outperform" rating on shares of Stevanato Group in a research report on Friday. Wolfe Research began coverage on shares of Stevanato Group in a report on Friday, December 13th. They issued an "outperform" rating and a $28.00 target price on the stock. Finally, Bank of America increased their price target on shares of Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a report on Friday, December 13th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of €27.75 ($30.16).
Check Out Our Latest Stock Analysis on Stevanato Group
About Stevanato Group
(
Get Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Read More
Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
